Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenal Hyperplasia, Congenital | 4 | 2021 | 34 | 0.940 |
Why?
|
| Hypertriglyceridemia | 1 | 2025 | 114 | 0.850 |
Why?
|
| Hydrocortisone | 3 | 2021 | 226 | 0.650 |
Why?
|
| Glucocorticoids | 3 | 2021 | 386 | 0.590 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 861 | 0.520 |
Why?
|
| Menarche | 1 | 2014 | 35 | 0.440 |
Why?
|
| Uterine Hemorrhage | 1 | 2014 | 43 | 0.430 |
Why?
|
| Puberty, Precocious | 1 | 2014 | 29 | 0.430 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 2014 | 4 | 0.430 |
Why?
|
| Cushing Syndrome | 1 | 2014 | 20 | 0.430 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 211 | 0.420 |
Why?
|
| Quinazolines | 1 | 2014 | 176 | 0.390 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 230 | 0.390 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 149 | 0.380 |
Why?
|
| Piperidines | 1 | 2014 | 235 | 0.370 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 250 | 0.340 |
Why?
|
| Pancreatitis | 1 | 2025 | 140 | 0.210 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2008 | 80 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2013 | 803 | 0.200 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2008 | 119 | 0.200 |
Why?
|
| Muscular Diseases | 3 | 2008 | 117 | 0.200 |
Why?
|
| Polyadenylation | 1 | 2023 | 50 | 0.190 |
Why?
|
| Mitochondria, Muscle | 4 | 2008 | 38 | 0.170 |
Why?
|
| Puberty | 1 | 2021 | 104 | 0.170 |
Why?
|
| Steroids | 1 | 2021 | 173 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2013 | 110 | 0.170 |
Why?
|
| Zebrafish | 1 | 2023 | 417 | 0.160 |
Why?
|
| Muscle, Skeletal | 4 | 2008 | 1035 | 0.140 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2015 | 74 | 0.140 |
Why?
|
| Circadian Rhythm | 2 | 2021 | 317 | 0.130 |
Why?
|
| Appetite Regulation | 1 | 2017 | 44 | 0.130 |
Why?
|
| Infusions, Subcutaneous | 1 | 2016 | 7 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 87 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2017 | 117 | 0.130 |
Why?
|
| Male | 12 | 2025 | 64877 | 0.120 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2016 | 2 | 0.120 |
Why?
|
| Receptors, Vasopressin | 1 | 2016 | 14 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2021 | 698 | 0.120 |
Why?
|
| Bone Density | 2 | 2018 | 367 | 0.120 |
Why?
|
| Biomarkers | 4 | 2021 | 3405 | 0.120 |
Why?
|
| Adolescent | 5 | 2025 | 20535 | 0.120 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 98 | 0.120 |
Why?
|
| Growth and Development | 1 | 2015 | 22 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 232 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2025 | 14732 | 0.110 |
Why?
|
| Siblings | 1 | 2016 | 202 | 0.110 |
Why?
|
| Hormones | 1 | 2015 | 170 | 0.110 |
Why?
|
| Female | 11 | 2025 | 70592 | 0.110 |
Why?
|
| Wrist | 1 | 2014 | 26 | 0.110 |
Why?
|
| Humans | 19 | 2025 | 131934 | 0.110 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2014 | 69 | 0.110 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2014 | 88 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2014 | 44 | 0.110 |
Why?
|
| Child | 5 | 2025 | 25761 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2014 | 38 | 0.100 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2014 | 75 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 876 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2012 | 22 | 0.090 |
Why?
|
| Radiography | 1 | 2014 | 819 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1410 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 320 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2023 | 166 | 0.070 |
Why?
|
| Young Adult | 3 | 2021 | 9952 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 916 | 0.070 |
Why?
|
| Mitochondrial Myopathies | 1 | 2007 | 28 | 0.070 |
Why?
|
| Body Mass Index | 3 | 2021 | 1696 | 0.070 |
Why?
|
| Adult | 5 | 2021 | 31538 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2008 | 785 | 0.060 |
Why?
|
| Ischemia | 1 | 2008 | 370 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 772 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2023 | 145 | 0.050 |
Why?
|
| Introns | 1 | 2023 | 305 | 0.050 |
Why?
|
| Sulfates | 1 | 2021 | 35 | 0.050 |
Why?
|
| Mutation | 1 | 2016 | 6227 | 0.050 |
Why?
|
| Aldehydes | 2 | 2013 | 31 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 17375 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 163 | 0.040 |
Why?
|
| Exons | 1 | 2023 | 805 | 0.040 |
Why?
|
| Aging | 2 | 2017 | 1248 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 30 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 241 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 456 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2017 | 19 | 0.030 |
Why?
|
| Ghrelin | 1 | 2017 | 56 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2017 | 83 | 0.030 |
Why?
|
| Glucagon | 1 | 2017 | 151 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 170 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 134 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 415 | 0.030 |
Why?
|
| Leptin | 1 | 2017 | 219 | 0.030 |
Why?
|
| Pregnanediones | 1 | 2015 | 1 | 0.030 |
Why?
|
| 5-alpha-Dihydroprogesterone | 1 | 2015 | 1 | 0.030 |
Why?
|
| Androsterone | 1 | 2015 | 3 | 0.030 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2015 | 9 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 207 | 0.030 |
Why?
|
| Androstenedione | 1 | 2015 | 15 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2012 | 1233 | 0.030 |
Why?
|
| Animals | 5 | 2023 | 34785 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 1 | 2015 | 33 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 308 | 0.030 |
Why?
|
| Prednisone | 1 | 2015 | 253 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 550 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 412 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 62 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2013 | 6 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2015 | 274 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 824 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2013 | 45 | 0.030 |
Why?
|
| Progesterone | 1 | 2015 | 451 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 677 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 241 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 4752 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 799 | 0.020 |
Why?
|
| Spirometry | 1 | 2012 | 75 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1044 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1033 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2899 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1017 | 0.020 |
Why?
|
| Vitamin D | 1 | 2012 | 183 | 0.020 |
Why?
|
| Seasons | 1 | 2012 | 327 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3770 | 0.020 |
Why?
|
| Myocardium | 1 | 2015 | 906 | 0.020 |
Why?
|
| Testosterone | 1 | 2015 | 611 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8542 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2674 | 0.020 |
Why?
|
| ATP Synthetase Complexes | 1 | 2008 | 1 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2008 | 18 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 2158 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1330 | 0.020 |
Why?
|
| Hindlimb | 1 | 2008 | 76 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2007 | 32 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2008 | 49 | 0.020 |
Why?
|
| Electron Transport | 1 | 2007 | 57 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2007 | 51 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1440 | 0.020 |
Why?
|
| Carnitine | 1 | 2007 | 69 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 176 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 336 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 110 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 87 | 0.020 |
Why?
|
| Lung | 1 | 2015 | 1555 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2007 | 89 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2007 | 124 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10935 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3760 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3409 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2007 | 242 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2007 | 188 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 2221 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 28947 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2007 | 850 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5408 | 0.010 |
Why?
|
| Exercise | 1 | 2008 | 858 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 1891 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13047 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 2438 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 21390 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12995 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 18461 | 0.010 |
Why?
|